| Jun 24 |
Harrow Successfully Manufactures Triesence; Management Credibility Soars
|
| Jun 20 |
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
| Jun 20 |
Biggest stock movers today: NVDA, DJT, ACN, and more
|
| Jun 20 |
Harrow's successful manufacture of Triesence points towards 2024 relaunch, shares rise
|
| Jun 20 |
Harrow Provides TRIESENCE® Relaunch Update
|
| Jun 6 |
Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
|
| Jun 5 |
Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study
|
